India’s next-generation sequencers market to post 11% CAGR through 2033

NGS is being applied to clinical oncology for personalised cancer treatments.

India’s next-generation sequencers (NGS) market is poised to grow through 2033 at a compound annual growth rate (CAGR) of around 11%, according to GlobalData.

The report revealed that the market is increasingly being applied in clinical oncology to advance personalised cancer treatments.

Meanwhile, the market’s adoption surge is driven by advancements in technology for more accurate and specific screening.

“As NGS scales up, reduction in costs and enhanced accessibility of these technologies hold the potential to expand the implementation and improve the patient outcomes globally,” Shreya Jain, Medical Devices Analyst at GlobalData, said.

Moreover, Jain mentioned that such growth will contribute to developing novel therapies and cancer research.